Pituitary neuroendocrine tumors: from old treatments to innovations, from efficacy to tolerance, from benignity to carcinomas, where do we stand now? - Aix-Marseille Université Access content directly
Journal Articles Best Practice and Research: Clinical Endocrinology and Metabolism Year : 2022

Pituitary neuroendocrine tumors: from old treatments to innovations, from efficacy to tolerance, from benignity to carcinomas, where do we stand now?

Abstract

No abstract available
Fichier principal
Vignette du fichier
Editorial.pdf (185.19 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-04034400 , version 1 (18-04-2023)

Identifiers

Cite

Frederic Castinetti, Gerald Raverot. Pituitary neuroendocrine tumors: from old treatments to innovations, from efficacy to tolerance, from benignity to carcinomas, where do we stand now?. Best Practice and Research: Clinical Endocrinology and Metabolism, 2022, 36 (6), pp.101717. ⟨10.1016/j.beem.2022.101717⟩. ⟨hal-04034400⟩
51 View
19 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More